戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y available drugs, including chemotherapies, rheumatologic agents, and novel ferroptosis inducers und
2 erstanding the pathogenesis and treatment of rheumatologic and glomerular diseases such as systemic l
3 mmatory, somatic) syndrome is a disease with rheumatologic and hematologic features caused by somatic
4  disease spectra ranging from hematologic to rheumatologic and immunologic disorders is crucial for i
5                    The cause of LVV is often rheumatologic and includes giant cell arteritis and Taka
6 xpensive, and they may be more effective for rheumatologic and nonocular autoimmune disorders than fo
7 n scales can be successfully integrated into rheumatologic and orthopedic procedures.
8                                              Rheumatologic and periodontal condition was evaluated in
9                             MMF use in other rheumatologic and renal diseases has been evaluated in o
10 n which these agents have been used to treat rheumatologic and renal diseases.
11  individuals (45%) did not meet criteria for rheumatologic and/or hematologic diagnoses previously as
12 the therapeutic armamentarium for oncologic, rheumatologic, and neurologic disorders has resulted in
13                                  Orthopedic, rheumatologic, and other subspecialty referrals may be c
14             Only recently have the potential rheumatologic applications for these agents been investi
15                                  Advances in rheumatologic arthritis health services research continu
16               In the subgroup that underwent rheumatologic assessment, a classification of inflammato
17 ve inflammatory back pain to refer for early rheumatologic assessment.
18 racting PET measures from joints examined by rheumatologic assessments was demonstrated.
19 m the resulting images and compared with the rheumatologic assessments.
20 were required to fulfill four of 11 American Rheumatologic Association criteria for the diagnosis of
21 ence of patients with RA receiving inpatient rheumatologic care and have the potential to significant
22 ach, we are now able to give the patient the rheumatologic care they want and need at a time they wan
23              Service developments to improve rheumatologic care will be specific to local circumstanc
24       The ROC application is useful in daily rheumatologic care, and the disease activity calculator
25 populations, which may limit their access to rheumatologic care.
26 egies are best to improve care at particular rheumatologic centers.
27  to date has been of 16 409 patients from 30 rheumatologic centres.
28 ded among these complications are a range of rheumatologic complications, including inflammatory arth
29                            Fibromyalgia is a rheumatologic condition characterized by multiple and ch
30 nt significant pediatric arthritis and other rheumatologic conditions (SPARC).
31 tive in decreasing arthralgia resulting from rheumatologic conditions and reducing serum triglyceride
32                                Patients with rheumatologic conditions frequently use CAM.
33 strated activity in various dermatologic and rheumatologic conditions in addition to Crohn's disease.
34 ing the national prevalence of arthritis and rheumatologic conditions in children on an ongoing basis
35 to a different intervention for a variety of rheumatologic conditions including osteoporosis, rheumat
36  these metabolic conditions clinically mimic rheumatologic conditions owing to non-specific arthralgi
37 he development of quality measures for adult rheumatologic conditions, and preliminary quality measur
38 n essential treatment for many patients with rheumatologic conditions, has recently garnered widespre
39  or biologic therapies for the management of rheumatologic conditions, malignancies, inflammatory bow
40 us disease 2019 as well as for patients with rheumatologic conditions, such as systemic lupus erythem
41 are visits for pediatric arthritis and other rheumatologic conditions.
42                                              Rheumatologic data (duration of illness, Disease Activit
43  patients with SSc who were seen at Stanford Rheumatologic Dermatology Clinic between January 1, 1998
44  at a single-center referral-based specialty rheumatologic-dermatology clinic in Philadelphia, Pennsy
45                      Dentists, masked to the rheumatologic diagnoses, performed periodontal probing a
46 reviews provided demographic information and rheumatologic diagnoses.
47 -1.77), renal disease (1.28; 1.11-1.48), and rheumatologic disease (2.04; 1.71-2.42).
48 icrobiologic findings and their influence on rheumatologic disease parameters in patients with rheuma
49 V infection in humans suffering from chronic rheumatologic disease symptoms, little is known about ch
50 dress the relationship between endocrine and rheumatologic disease, both of which are autoimmune.
51  gastrointestinal events, anticoagulant use, rheumatologic disease, high Deyo comorbidity index score
52    Osteoarthritis is the most common form of rheumatologic disease, with numerous factors increasing
53 onary fibrosis.IMPORTANCE A variety of human rheumatologic disease-causing mutations have recently be
54  a complication of infection, malignancy, or rheumatologic disease.
55 ling, a target of FDA approved therapies for rheumatologic disease.
56 ious central nervous system complications of rheumatologic diseases has been gained in the past year.
57           The pathogenesis of paraneoplastic rheumatologic diseases is complex and not fully understo
58 S, lymphoma, solid tumor without metastasis, rheumatologic diseases, alcohol and drug abuse, psychose
59                             Similar to other rheumatologic diseases, an association of relapsing poly
60 ulation modulator, used for the treatment of rheumatologic diseases, and was recently the first drug
61 s extremely useful in the early diagnosis of rheumatologic diseases, as well as in the monitoring of
62 specific in detecting the common findings in rheumatologic diseases, such as bone marrow oedema, cart
63         Despite being one of the most common rheumatologic diseases, there is still no disease-modify
64 alpha agents are used widely in treatment of rheumatologic diseases.
65 umatologists for the evaluation of suspected rheumatologic diseases.
66 ial diagnosis are discussed for these common rheumatologic diseases.
67 eview the single-gene defects that can mimic rheumatologic diseases.
68 ion of the role of innate immunity in common rheumatologic diseases.
69 ed during the course of the past year on the rheumatologic diseases.
70 methasone led to the accepted diagnosis of a rheumatologic disorder resembling Behcet disease.
71 t on the care of a woman hospitalized with a rheumatologic disorder.
72 on, or perirectal abscess) and/or autoimmune/rheumatologic disorders (AIDs).
73  We discuss the association between specific rheumatologic disorders and AITDs and manifestations of
74 e in understanding the experience of pain in rheumatologic disorders as well as other chronic pain co
75 nic autoinflammatory diseases are a group of rheumatologic disorders caused by dysregulation in the i
76 ho had taken minocycline for dermatologic or rheumatologic disorders for extended periods.
77                                    AITDs and rheumatologic disorders have significant commonalities b
78 in patients with chronic kidney diseases and rheumatologic disorders.
79 AITDs and manifestations of AITDs that mimic rheumatologic disorders.
80 ses, including infections, malignancies, and rheumatologic disorders.
81 linical use for the treatment of malaria and rheumatologic disorders.
82 on syndrome (MAS) constitutes one of the few rheumatologic emergencies.
83                   Septic arthritis (SA) is a rheumatologic emergency associated with significant morb
84 fficult to distinguish from those of various rheumatologic entities.
85 -AIA cohorts, respectively, were positive on rheumatologic evaluation but negative on TB PET.
86 T qualitative assessments and joint-by-joint rheumatologic evaluation in the AIA and non-AIA cohorts
87            Patients underwent neurologic and rheumatologic evaluation, electromyography, and muscle b
88 rformed transesophageal echocardiography and rheumatologic evaluations in 69 patients with systemic l
89 initial transesophageal echocardiography and rheumatologic evaluations.
90 on of TB PET/CT measures with joint-by-joint rheumatologic examination and standardized rheumatologic
91 .8% joints, respectively, deemed negative on rheumatologic examination showed PET positivity.
92       Twenty-five patients underwent further rheumatologic examination.
93             Disease activity was assessed by rheumatologic examination.
94 lence of somatic UBA1 variation; presence of rheumatologic, hematologic, pulmonary, dermatologic, and
95 rtain endocrine disease occurs more often in rheumatologic illness will enable the clinician to inves
96 nd adult patients with DADA2 presenting with rheumatologic/immunologic symptoms or severe hematologic
97 ing has been evaluated in many oncologic and rheumatologic indications and is emerging as a powerful
98    Among patients with a prHBV infection and rheumatologic indications for long-term biologic therapi
99 f underlying conditions, including allergic, rheumatologic, infectious, and neoplastic disorders.
100  of ocular manifestations in immunologic and rheumatologic inflammatory disorders has continued to ex
101  from rheumatologic procedures, 261,584 from rheumatologic infusions, and 11,101 US dollars from init
102                               Often, general rheumatologic laboratory tests are sent which are not ne
103       The total number of manuscripts in the rheumatologic literature with an ethical focus was 104 o
104 familial HLH) or be secondary to infectious, rheumatologic, malignant, or metabolic conditions (acqui
105 nts in the medical literature related to the rheumatologic manifestations and their detection and man
106 ease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of
107 hritis, at least before the advent of modern rheumatologic medications.
108 ive resource for postmarketing evaluation of rheumatologic medications.
109 H can also occur in patients with underlying rheumatologic or autoinflammatory disorders and is usual
110  and scleritis only in patients referred for rheumatologic or ocular inflammation.
111  patients receiving a TNFi for dermatologic, rheumatologic, or gastroenterologic diagnoses, then cate
112      Only respiratory, gastrointestinal, and rheumatologic/orthopedic/psychiatric complex chronic con
113 Spearman rho = 0.53-0.70, P < 0.05) with the rheumatologic outcome measures.
114 t rheumatologic examination and standardized rheumatologic outcome measures.
115 k of hepatitis B virus (HBV) reactivation in rheumatologic patients with a previously resolved HBV (p
116                    A total of 1218 Caucasian rheumatologic patients, admitted consecutively as outpat
117 s in rheumatology and their applicability to rheumatologic practice.
118 om radiologic studies, 8,159 US dollars from rheumatologic procedures, 261,584 from rheumatologic inf
119 nary workup after several gastroenterologic, rheumatologic, radiologic, psychiatric and orthopedic co
120 HL]); endocrine (diabetes, thyroiditis); and rheumatologic (Sjogren's syndrome).
121 ormity and are not associated with any other rheumatologic stigmata.
122  of having some of the more common pediatric rheumatologic symptoms and diseases.
123 ve estimated the cost-effectiveness of novel rheumatologic therapies, in particular the inhibitors of
124 iologic studies, consultations, and specific rheumatologic treatments and procedures performed or ord
125               The authors also discuss novel rheumatologic uses for the older agents that have been d

 
Page Top